Peptide Initiative

Peptide profile · Healing & Recovery

Angiotensin (1-7)

The heart-friendly peptide that balances your blood pressure and protects your cardiovascular system

Moderate human trialsResearch compound
Approximately 2-6 hoursHalf-life (varies by route of administration)
Varies by route of administrationBioavailability
899.02Molecular weight, g/mol

Molecular formula

C41H62N12O11

CAS number
25016-41-7
PubChem
123805
Developed · 1995
Research Team, Academic Research Institutions

Amino acid sequence

Asp-Arg-Val-Tyr-Ile-His-Pro

Heart Health & ProtectionProtects heart tissue from damage and inflammation

8.2

Blood Pressure BalanceHelps balance blood pressure naturally

7.8

Anti-Inflammatory SupportReduces inflammation throughout the cardiovascular system

7.4

Ratings out of 10.

100 mcg/kg

Enter your weight to see your dose.

Every documented dose level

PhaseDoseFrequencyRoute
Up to 6 chemotherapy cycles100 mcg/kgOnce daily after each chemotherapy sessionSubcutaneous
Up to 10 days0.5 mg/kgOnce dailyIntravenous
Build my protocolBuild my protocol opens your schedule and dose log to save, share and keep on your phone.

Best for cardiovascular health and heart protection & blood pressure management and hypertension

Best for

  • Cardiovascular health and heart protection

    Angiotensin (1-7) is particularly well-suited for individuals focused on cardiovascular health and heart protection. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Blood pressure management and hypertension

    Angiotensin (1-7) is particularly well-suited for individuals focused on blood pressure management and hypertension. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Recovery from heart-related conditions

    Angiotensin (1-7) is particularly well-suited for individuals focused on recovery from heart-related conditions. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Anti-inflammatory support

    Angiotensin (1-7) is particularly well-suited for individuals focused on anti-inflammatory support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Consider alternatives if

Alternative approaches for healing & recovery supportConsult your healthcare provider for alternatives to Angiotensin (1-7) based on your specific needs and medical history
Alternative healing peptidesBPC-157TB-500 (Thymosin Beta-4)GHK-Cu
Non-peptide recovery optionsPlatelet-Rich Plasma (PRP)Collagen supplementsPhysical therapy

Do not use if

  • Severe hypotension or uncontrolled low blood pressure
  • Acute myocardial infarction in early stages
  • Concurrent use with certain ACE inhibitors without medical supervision
  • Pregnancy and breastfeeding (insufficient safety data)

Use with caution if

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Angiotensin (1-7) use
  • You have any chronic health conditions that require regular monitoring

Not sure?

Compare Angiotensin (1-7) with similar peptides to find the best fit for your goals.

Route

Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training

Best sites

  • Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
  • Front of thighs—middle to upper portion of the outer leg
  • Back of upper arm—outer area (may need assistance from another person)

The Angiotensin (1-7) dosing protocol covers how it is taken.

4 common side effects · 1 serious

Emergency signs first, then what this page and MedlinePlus say.

Angiotensin (1-7) is not FDA-approved.

Human data come from small cancer trials: a completed phase I dose-escalation and pharmacokinetic study and a randomized, placebo-controlled phase 2 study alongside chemotherapy that reported no drug-related safety issues .

Animal studies suggest potential benefits in hypertension and cardiac remodeling but also reveal risks of hypotension, particularly with concurrent ACE inhibitor or ARB therapy. The peptide's effects on systemic inflammation and immune function in animal models are not validated in humans.

Human pharmacokinetic data are limited to the phase I study, which set 400 µg/kg as the recommended dose for its once-daily, 5-day schedule .

Human evidence comes from small cancer trials: a completed phase I dose-escalation and pharmacokinetic study in 18 patients with advanced solid tumors, in which stroke and reversible cranial neuropathy were dose-limiting at 700 µg/kg , and a randomized, placebo-controlled phase 2 study in 34 patients receiving chemotherapy that reported no drug-related safety issues .

Beyond these, published literature focuses on proof-of-concept animal efficacy rather than comprehensive safety profiles.


Common side effects · experienced by some users

Hypotension (Low Blood Pressure)

This effect has a common likelihood of occurring. Within 15-30 minutes of injection

Management
Start with low doses. Lie down during injection. Monitor BP regularly. Drink adequate fluids and salt unless restricted. Report severe dizziness.

Dizziness or Lightheadedness

This effect has a common likelihood of occurring. Immediate to 1-2 hours

Management
Sit or lie down immediately after injection. Rise slowly from lying or sitting position. Stay hydrated. Usually resolves within a few hours.

Injection Site Reactions

This effect has a common likelihood of occurring. Immediately at injection site

Management
Rotate injection sites. Apply ice for 5-10 minutes if desired. Keep site clean. Most resolve within a few hours.

Headache

This effect has a moderate likelihood of occurring. 15 minutes to 2 hours

Management
Stay hydrated. Rest in quiet, dark room. May take over-the-counter pain relievers if approved. Usually mild and temporary.

Serious side effects

Hyperkalemia (High Potassium)

This effect has a uncommon but serious likelihood of occurring. Can develop gradually over days or acutely

Management
Regular blood tests to monitor potassium. Avoid potassium supplements. Limit high-K foods. Seek medical attention if palpitations, chest pain, or muscle weakness develop.


Stop and seek help if

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Angiotensin (1-7)
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Angiotensin (1-7) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.


With other peptides

  • SafeAngiotensin Converting Enzyme 2 (ACE2) — Works synergistically in the RAS system to produce Angiotensin (1-7)
  • SafeLosartan — Blocks negative Angiotensin II receptors while allowing protective pathways
  • SafePerindopril — ACE inhibitor that shifts RAS balance toward protective peptides

With medications

  • CautionNSAIDs (High-Dose) — May reduce effectiveness and increase kidney injury risk
  • CautionPotassium Supplements — Risk of dangerous potassium elevation (hyperkalemia)
  • CautionCertain Diuretics — May compound electrolyte imbalances and blood pressure effects

With supplements

  • SafeMultivitamins — Generally safe to take alongside Angiotensin (1-7). Space doses apart if taking oral formulations to ensure optimal absorption.
  • SafeElectrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Moderate human trials · first signs week 1

Evidence level

Moderate human trials

(Phase 1-2)

80/100

Regulatory status

Research compound

Onset of effects

Moderate

(1-2 weeks)


How it works

Angiotensin 1-7 is a naturally occurring peptide that counterbalances angiotensin II's harmful effects.

While angiotensin II narrows blood vessels and promotes inflammation, angiotensin 1-7 widens them and reduces inflammation, potentially protecting heart and kidney function.

The deeper mechanism

Angiotensin 1-7 is a heptapeptide generated by ACE2 or other peptidases from angiotensin II. It acts as an agonist at the Mas receptor, promoting vasodilation, reducing inflammation, and antagonizing angiotensin II signaling.

In the renin-angiotensin system, Ang 1-7 provides cardioprotective and renoprotective counter-regulation.


What to expect

  1. Week 1

    What you might notice

    • Your body begins responding immediately
    • Blood vessels start to relax and inflammation decreases
    • You might notice slight improvement in energy or reduced bloating
    • Blood pressure begins adjusting—monitor daily

    What's normal

    • Initial response to Angiotensin (1-7) is beginning at the cellular level
    • Different individuals experience Angiotensin (1-7)'s onset at different rates
    • Transient systemic effects from initial Angiotensin (1-7) exposure are common

    What's next

    • Maintain consistent Angiotensin (1-7) administration as prescribed
    • Document subjective effects and physical markers daily
    • Schedule a check-in with your provider about initial observations
  2. Weeks 2-4

    What you might notice

    • Initial protective effects become more noticeable
    • Cardiovascular function improves as the Mas receptor pathway activates more consistently
    • Some people notice improved sleep quality or reduced puffiness
    • Kidney function begins improving if kidney support is a goal

    What's normal

    • Angiotensin (1-7) is now achieving steady-state pharmacokinetics
    • Measurable changes aligned with Angiotensin (1-7)'s mechanism may appear
    • Initial adjustment effects typically resolve by this point

    What's next

    • Maintain Angiotensin (1-7) dosing exactly as established
    • Track progress toward intended outcomes in detail
    • Review lab work or biomarker changes with your healthcare team
  3. Weeks 4-8

    What you might notice

    • Significant cardiovascular improvements appear
    • Blood pressure stabilizes at healthier levels
    • Inflammation markers drop noticeably
    • Energy and exercise tolerance improve

    What's normal

    • Angiotensin (1-7) is now achieving steady-state pharmacokinetics
    • Measurable changes aligned with Angiotensin (1-7)'s mechanism may appear
    • Initial adjustment effects typically resolve by this point

    What's next

    • Maintain Angiotensin (1-7) dosing exactly as established
    • Track progress toward intended outcomes in detail
    • Review lab work or biomarker changes with your healthcare team
  4. Months 2-3

    What you might notice

    • Sustained benefits become established
    • Long-term cardiovascular protection increases
    • Many users report feeling more energetic and healthier overall
    • Kidney protection becomes measurable through improved blood work

    What's normal

    • Full therapeutic effects of Angiotensin (1-7) are well-characterized at this point
    • Maintenance of Angiotensin (1-7)'s therapeutic effects is typical
    • Tolerance patterns with Angiotensin (1-7) are generally stable over months

    What's next

    • Comprehensive assessment of Angiotensin (1-7) efficacy should be conducted
    • Discuss long-term continuation, cycling, or protocol modifications
    • Continue regular monitoring of relevant biomarkers or symptoms

Signs it's working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Angiotensin (1-7) over time
  • Reduction in symptom frequency or severity

Signs it's working

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing results?

Common reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

How is Angiotensin (1-7) different from Angiotensin II?

Great question! While Angiotensin II tightens blood vessels, increases inflammation, and raises blood pressure, Angiotensin (1-7) does the opposite. It opens blood vessels, fights inflammation, protects your heart, and lowers blood pressure. They're like opposing players on a team—both natural, but with opposite effects. This is why Ang-(1-7) is called the 'protective' peptide.

Can I take Angiotensin (1-7) with my blood pressure medication?

This is important—ask your doctor first. Some blood pressure medications (like ACE inhibitors) work well with Ang-(1-7) because they complement each other. Others might cause your blood pressure to drop too much. Your doctor needs to monitor your blood pressure carefully if combining these. Never make changes without professional guidance.

Why do I feel dizzy after taking Ang-(1-7)?

Dizziness usually means your blood vessels are relaxing and blood pressure is dropping—which is what we want, but your body needs time to adjust. This is why we start with low doses. Lie down after injection, stay hydrated, and rise slowly from sitting or lying down. Most people adapt after the first few doses.

How do I know if Angiotensin (1-7) is working?

You'll notice several things: blood pressure readings improve (usually within weeks), you feel less bloated and tired, and exercise feels easier. Blood tests show improved kidney function and inflammation markers. Your doctor can run specific cardiovascular tests. Some benefits are subtle—better sleep, less brain fog, improved mood from better blood flow.

Is Angiotensin (1-7) safe for long-term use?

Research suggests it's safe for long-term use since your body produces it naturally, but long-term human studies are still ongoing. It's not FDA-approved yet, so it's considered a research compound. Most safety concerns come from using too much too fast or not monitoring blood work. Work with a knowledgeable healthcare provider and get regular blood tests.

Can Angiotensin (1-7) help with heart failure?

Research shows real promise. Ang-(1-7) protects heart tissue, reduces inflammation, and improves how efficiently your heart pumps. Several studies demonstrate it helps with heart failure recovery. However, this is still largely in the research phase. If you have heart failure, this is something to discuss with your cardiologist, not something to try on your own.

What should I eat while taking Angiotensin (1-7)?

Stay away from high-potassium foods because Ang-(1-7) can raise potassium levels. Avoid coconut water, avocados, spinach, and supplements with potassium. Eat plenty of other vegetables, lean proteins, and whole grains. Stay well-hydrated and don't drastically cut salt without asking your doctor—your body needs proper electrolyte balance.

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Angiotensin (1-7), on one page.

Angiotensin (1-7) dosing protocol

Medical disclaimer

Angiotensin (1-7) is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 12, 2026

100 mcg/kg Once daily after each chemotherapy session · onset 1-2 weeks
Open the Angiotensin (1-7) calculatorAngiotensin (1-7) calculator